Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 32,2023 No.1
The title
The title
The keywords
The author
New Online
Vol 33,2024
Vol 32,2023
No.12
No.11
No.10
No.9
No.8
No.7
No.6
No.5
No.4
No.3
No.2
No.1
Contents
Vol 32,2023 No.1
Date of publication: January 15, 2023
Get cover
Get contents
Next
Vol 32,2023 No.2
Data mining and analysis for safety signals of degarelix based on openFDA
Fu-Rong ZHOU
Bei ZHANG
Hui-Xiang LI
Qing-Na WU
Chen-Yu GUO
2023,32(1):52-59
Degarelix
OpenFDA
Adverse drug event
Signal detection
Data mining
Details
Download
Mobile
Meta-analysis of the efficacy of oral probiotics in adults with type 2 diabetes mellitus
Yun-Jie TENG
Ying-Hong WANG
Jing CHEN
Ming-Chen ZHANG
2023,32(1):60-71
Probiotics
Type 2 diabetes
Adults
Meta-analysis
Meta-regression
Randomized controlled trial
Details
Download
Mobile
Effect of palonosetron combination dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a Meta analysis
Tao ZHANG
Miao-Miao MA
Hao-Ke ZHANG
Liang TENG
2023,32(1):72-81
Palonosetron
Laparoscopic surgery
Postoperative nausea and vomiting
Dexamethasone
Meta-analysis
Randomized controlled trial
Details
Download
Mobile
Pharmacoeconomic evaluation of Huangkui capsule versus losartan potassium tablets in the treatment of IgA nephropathy
Liang-Wen GOU
Zhao-Ting GUO
Qiong LUO
Nan YANG
Ming HU
2023,32(1):02-09
Huangkui capsule
Losartan potassium tablets
Chronic kidney disease
Pharmacoeconomics
Cost-utility analysis
Details
Download
Mobile
Rationality analysis of off-label use of chlorpromazine in real world
Yi-Long YAN
Zhao-Jian WANG
Shan-Shan GUO
Zhi-Gang ZHAO
Cao LI
Ji-Ping HUO
2023,32(1):10-17
Chlorpromazine
Off-label drug use
Poly-pharmacy
Real-world
Details
Download
Mobile
Efficacy and safety of generic paroxetine tablets in centralized drug procurement: a real-world study
Fei JIA
Yan-Nan ZANG
Meng-Xi NIU
Shan-Shan LIU
Hong-Yan ZHUANG
guowe@ccmu.edu.cn Wei GUO
2023,32(1):18-24
Drug centralized procurement
Paroxetine
Efficacy
Safety
Real-world study
Details
Download
Mobile
Analysis of cross allergy warning signs in 641 instructions for non-antibacterial drugs with sulfonamide structure and prescription audit suggestions
Xuan LIU
Long YUAN
Wei LI
Yu LIU
2023,32(1):25-29
Sulfonamides
Non-antibacterial drugs
Cross hypersensitivity
Drug instructions
Drug risk management
Details
Download
Mobile
Construction of hospital medicine list management index system based on Delphi method
Guang-Quan SU
Hui CHEN
Shuang-Ying GUI
Ai-Zong SHEN
2023,32(1):30-35
Delphi method
Medical institutions
Medicine list
Index system
Details
Download
Mobile
Effects of knee intra-articular injection of sodium hyaluronate combined with compound betamethasone on pain symptoms and knee function of patients with knee synovitis in plateau area
Chen-Zhu YIN
Bo YANG
Hao HU
Ji-Lin XIANG
Yu ZHANG
Fu YAO
Lan ZHANG
2023,32(1):36-43
Sodium hyaluronate
Compound betamethasone
Knee synovitis
Pain symptoms
Knee func-tion
Inflammatory factors
Details
Download
Mobile
Clinical observation of Yanghe Tongmai pills combined with alprostadil for diabetic lower limb arteriosclerosis obliterans
Wu-Bao KONG
Jin WU
Xiao-Yun WANG
Shu-Quan LYU
Hong-Min ZHAO
2023,32(1):44-51
Yanghe Tongmai pills
Alprostadil
Diabetic
Lower limb arteriosclerosis obliterans
Clinical efficacy
Details
Download
Mobile
Application of machine learning in the individualized therapy of tacrolimus in transplant patients
Xiao-Ling LU
Bing CHEN
2023,32(1):82-88
Tacrolimus
Therapeutic drug monitoring
Machine learning
Individualized medication
Details
Download
Mobile
Analysis and discussion on the establishment of IDMC in clinical trials in China
Li-Ya CAO
Lin-Li XIE
Jiang-Chuan XIE
Xin-Mei PAN
Pan MA
Yong-Chuan CHEN
2023,32(1):89-94
Clinical trial
Safety
Independent data monitoring committee
Details
Download
Mobile
One case of maculopapule induced by amoxicillin after pembrolizumab treatment
Jing GONG
Xiao-Lin CHEN
Xue-Li LIU
Jun YANG
2023,32(1):95-98
Pembrolizumab
Amoxicillin
Maculopapular drug eruption
Immune activation
Details
Download
Mobile
Acute pancreatitis caused by bortezomib in multiple myeloma: a case report and literature review
Liang YANG
Zhen ZENG
Chuan-Cui LUO
Ling JIANG
Xiu-Jun LI
Xun-Rong ZHOU
2023,32(1):99-102
Bortezomib
Acute pancreatitis
Multiple myeloma
Adverse drug reaction
Details
Download
Mobile
A case report of anaphylactic shock induced by bevacizumab
Jing-Jing LIU
Yan-Sheng KANG
Xiao-Qin WANG
Wei ZHANG
He-Feng ZHANG
Tong WANG
2023,32(1):103-106
Bevacizumab
Anaphylactic shock
Adverse drug reactions
Case report
Details
Download
Mobile
Analysis of one case of anaphylaxis caused by cefazolin sodium in pregnant women
Xin ZHANG
Dong-Hong Tao
Qi-Hua WAN
2023,32(1):107-110
Cefazolin sodium
Pregnant women
Anaphylaxis
Case report
Details
Download
Mobile
Pharmaceutical care of a pregnancy complicated with schizophrenia and gestational diabetes mellitus
Lu ZHAO
Mei ZHANG
Wei LEI
Qing YE
Ji ZHANG
2023,32(1):111-115
Schizophrenia
Gestational diabetes mellitus
Clinical pharmacist
Pharmaceutical care
Details
Download
Mobile
Pharmaceutical care and individualized selection of liver protective drugs in a case of severe liver injury caused by pezopanib tablets
Zhi-Tao WANG
Ling-Fang HE
Yong-Hai LOU
2023,32(1):116-120
Pezopanib
Liver injury
Adverse drug reactions
Individualized administration
Pharmaceutical care
Details
Download
Mobile